Famotidine

法莫替丁

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameFamotidine
Drug Alias Name胃利赞famotidinefamotidinum胃得famotidina +[21] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H2 receptor antagonists
TargetsHistamine H2 receptor
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)SchizophreniaWounds and Injuries +[18] 
Global Approved IndicationsHeartburnStomach UlcerDuodenal Ulcer +[7] 
Approved Indications in ChinaHeartburnStomach UlcerDuodenal Ulcer +[6] 
Original Approved Country/TerritoryUnited States
Original Approved Date1986/10/15
Country/TerritoryCanadaUnited StatesSweden +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesValeant
China Registration ClassN/A

Develop Information

Active CompaniesKenvue Brands LlcUniversity Of Texas Medical BranchNorthwell Health, Inc +[5] 
Inactive CompaniesBausch Health Us LlcProfact IncSalix Pharmaceuticals +[10] 
Active IndicationsCoronavirus Disease 2019 (COVID-19)Wounds and InjuriesHeartburn +[12] 
Inactive IndicationsSchizophreniaDyskinesiasPeptic Ulcer +[6] 

Other Information

ATC CodeA02BA03
Related LinksWikipediaDrugBankKEGG